224 related articles for article (PubMed ID: 21962770)
1. Evidence based management guidelines for the detection and treatment of congenital CMV.
Kadambari S; Williams EJ; Luck S; Griffiths PD; Sharland M
Early Hum Dev; 2011 Nov; 87(11):723-8. PubMed ID: 21962770
[TBL] [Abstract][Full Text] [Related]
2. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
Yilmaz Çiftdogan D; Vardar F
J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
[TBL] [Abstract][Full Text] [Related]
3. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.
Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y
J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986
[TBL] [Abstract][Full Text] [Related]
4. Congenital cytomegalovirus: what the otolaryngologist should know.
Duval M; Park AH
Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):495-500. PubMed ID: 25222916
[TBL] [Abstract][Full Text] [Related]
5. Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!
Ronchi A; Shimamura M; Malhotra PS; Sánchez PJ
Expert Rev Anti Infect Ther; 2017 May; 15(5):417-419. PubMed ID: 28277819
[No Abstract] [Full Text] [Related]
6. "Minimally symptomatic" congenital cytomegalovirus infection: latest data and emerging concepts.
Howard A; Nishikawa JK; Sánchez PJ
Curr Opin Pediatr; 2024 Aug; 36(4):480-488. PubMed ID: 38747205
[TBL] [Abstract][Full Text] [Related]
7. The Yield of Targeted Examination for the Detection of Symptomatic Congenital Cytomegalovirus Infection.
Masarweh K; Felszer-Fisch C; Shinwell E; Hasanein J; Peniakov M; Weiner SA; Lurye-Marcu B; Miron D
Isr Med Assoc J; 2021 May; 23(5):318-322. PubMed ID: 34024050
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.
Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE
Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404
[TBL] [Abstract][Full Text] [Related]
9. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G
Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570
[No Abstract] [Full Text] [Related]
10. The use of saliva as a practical and feasible alternative to urine in large-scale screening for congenital cytomegalovirus infection increases inclusion and detection rates.
Cardoso ES; Jesus BL; Gomes LG; Sousa SM; Gadelha SR; Marin LJ
Rev Soc Bras Med Trop; 2015; 48(2):206-7. PubMed ID: 25992937
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of a flow chart for targeted screening of congenital cytomegalovirus-related hearing loss.
Ciccia M; Monari C; Vitagliano G; Zarro N; Sandri F
J Neonatal Perinatal Med; 2018; 11(3):339-343. PubMed ID: 30040746
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for congenital cytomegalovirus: Options for hospital-based and public health programs.
Grosse SD; Dollard S; Ross DS; Cannon M
J Clin Virol; 2009 Dec; 46 Suppl 4():S32-6. PubMed ID: 19783205
[TBL] [Abstract][Full Text] [Related]
13. From diagnosis to management: current perspectives on congenital cytomegalovirus infection.
Buchfellner M; Ross S
Curr Opin Infect Dis; 2024 Aug; 37(4):232-237. PubMed ID: 38748563
[TBL] [Abstract][Full Text] [Related]
14. [Therapy Options for Infants with Congenital Cytomegalovirus Infection - Implications for Setting Up Neonatal Screening Programs].
Bührer C; Blankenstein O; Rossi R;
Z Geburtshilfe Neonatol; 2020 Apr; 224(2):71-78. PubMed ID: 31426118
[TBL] [Abstract][Full Text] [Related]
15. Universal neonatal cytomegalovirus screening using saliva - report of clinical experience.
Barkai G; Ari-Even Roth D; Barzilai A; Tepperberg-Oikawa M; Mendelson E; Hildesheimer M; Kuint J
J Clin Virol; 2014 Aug; 60(4):361-6. PubMed ID: 24881490
[TBL] [Abstract][Full Text] [Related]
16. Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus.
Dollard SC; Schleiss MR; Grosse SD
J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S249-54. PubMed ID: 20532822
[TBL] [Abstract][Full Text] [Related]
17. Late-onset and congenital hearing loss detected using AABR due to congenital cytomegalovirus infection that improved with valganciclovir.
Morimoto C; Nishikubo T; Nishimura T; Onishi T; Takeyama M; Uchida Y; Otsuka S; Yamanaka T; Kitahara T
Congenit Anom (Kyoto); 2023 Mar; 63(2):40-43. PubMed ID: 36517460
[TBL] [Abstract][Full Text] [Related]
18. [Current Approaches in the Diagnosis and Management of Congenital Cytomegalovirus Infections and the Situation in Turkey].
Şahiner F
Mikrobiyol Bul; 2020 Jan; 54(1):171-190. PubMed ID: 32050888
[TBL] [Abstract][Full Text] [Related]
19. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
Amir J; Wolf DG; Levy I
Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and management of cytomegalovirus-associated congenital hearing loss.
Dobbie AM
Curr Opin Otolaryngol Head Neck Surg; 2017 Oct; 25(5):390-395. PubMed ID: 28857892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
